Implantable system for treprostinil: a real-world patient experience study

por Shapiro, Shelley, Bourge, Robert C., Pozella, Patti, Harris, David F., Borg, Erick H., Nelsen, Andrew C.
Publicado 2020

Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily

por Shapiro, Shelley, Mandras, Stacy, Restrepo-Jaramillo, Ricardo, Shen, Eric, Broderick, Meredith, Rao, Youlan, Lee, Dasom, Nelsen, Andrew C.
Publicado 2021

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial

por Nathan, Steven D., Tapson, Victor F., Elwing, Jean, Rischard, Franz, Mehta, Jinesh, Shapiro, Shelley, Shen, Eric, Deng, Chunqin, Smith, Peter, Waxman, Aaron
Publicado 2021

Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study

por Feldman, Jeremy P., Gomberg-Maitland, Mardi, Shapiro, Shelley M., Lautenbach, Amy A., Morris, Marty, Murphy, Jeff A., Waxman, Aaron B., Bourge, Robert C.
Publicado 2021

Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics

por White, R. James, Parikh, Keyur, Allen, Roblee, Feldman, Jeremy, Jerjez-Sanchez, Carlos, Pan, Lei, Keogh, Anne, Vizza, C. Dario, Shapiro, Shelley, Gordon, Kathryn, Broderick, Meredith, Bartolome, Sonja
Publicado 2020

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation

por Rahaghi, Franck F., Feldman, Jeremy P., Allen, Roblee P., Tapson, Victor, Safdar, Zeenat, Balasubramanian, Vijay P., Shapiro, Shelley, Mathier, Michael A., Elwing, Jean M., Chakinala, Murali M., White, R. James
Publicado 2017

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial

por Maron, Bradley A., Choudhary, Gaurav, Goldstein, Rebekah L., Garshick, Eric, Jankowich, Matthew, Tucker, Troo J. S., LaCerda, Kathleen A., Hattler, Brack, Dempsey, Edward C., Sadikot, Ruxana T., Shapiro, Shelley, Rounds, Sharon I., Goldstein, Ronald H.
Publicado 2022

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

por Bourge, Robert C, Tapson, Victor F, Safdar, Zeenat, Benza, Raymond L, Channick, Richard N, Rosenzweig, Erika B, Shapiro, Shelley, White, Richard James, McSwain, Christopher Shane, Gotzkowsky, Stephen Karl, Nelsen, Andrew C, Rubin, Lewis J
Publicado 2013

Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial

por Gomberg-Maitland, Mardi, Bourge, Robert C., Shapiro, Shelley M., Tarver, James H., Zwicke, Dianne L., Feldman, Jeremy P., Chakinala, Murali M., Frantz, Robert P., Torres, Fernando, Bag, Remzi, Murphy, Jeffrey A., Lautenbach, Amy A., Morris, Marty, Peterson, Leigh, Waxman, Aaron B.
Publicado 2019

Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study

por Saggar, Rajeev, Giri, Paresh C., Deng, Chunqin, Johnson, Dana, McCloy, Mary K., Liang, Lloyd, Shaikh, Faisal, Hong, Jason, Channick, Richard N., Shapiro, Shelley S., Lynch, Joseph P., Belperio, John A., Weigt, Samuel S., Ramsey, Allison L., Ross, David J., Sayah, David M., Shino, Michael Y., Derhovanessian, Ariss, Sherman, Alexander E., Saggar, Rajan
Publicado 2021

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

por Spikes, Leslie A., Bajwa, Abubakr A., Burger, Charles D., Desai, Sapna V., Eggert, Michael S., El‐Kersh, Karim A., Fisher, Micah R., Johri, Shilpa, Joly, Joanna M., Mehta, Jinesh, Palevsky, Harold I., Ramani, Gautam V., Restrepo‐Jaramillo, Ricardo, Sahay, Sandeep, Shah, Trushil G., Deng, Chunqin, Miceli, Melissa, Smith, Peter, Shapiro, Shelley M.
Publicado 2022

Capillary Proliferation in Systemic‐Sclerosis‐Related Pulmonary Fibrosis: Association with Pulmonary Hypertension

por Seki, Atsuko, Anklesaria, Zafia, Saggar, Rajeev, Dodson, Mark W., Schwab, Kristin, Liu, Ming‐Chang, Charan Ashana, Deepshikha, Miller, William D., Vangala, Sitaram, DerHovanessian, Ariss, Channick, Richard, Shaikh, Faisal, Belperio, John A., Weigt, Stephen S., Lynch, Joseph P., Ross, David J., Sullivan, Lauren, Khanna, Dinesh, Shapiro, Shelley S., Sager, Jeffrey, Gargani, Luna, Stanziola, Anna, Bossone, Eduardo, Schraufnagel, Dean E., Fishbein, Gregory, Xu, Haodong, Fishbein, Michael C., Wallace, William D., Saggar, Rajan
Publicado 2019